According to Vistin Pharma's latest financial reports the company has a price-to-book ratio of 2.59391.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | 3.42 | 6.69% |
2023-12-31 | 3.20 | 24.95% |
2022-12-31 | 2.56 | -17.79% |
2021-12-31 | 3.12 | 9.71% |
2020-12-31 | 2.84 | 154.63% |
2019-12-31 | 1.12 | 17.64% |
2018-12-31 | 0.9483 | -48.21% |
2017-12-31 | 1.83 | -16.52% |
2016-12-31 | 2.19 | 10.53% |
2015-12-31 | 1.98 |